Erica De Candia

Posts

Bleeding complications and platelet dysfunction in patients with lymphoproliferative disease receiving Bruton tyrosine kinase inhibitors
Methodology

Bleeding complications and platelet dysfunction in patients with lymphoproliferative disease receiving Bruton tyrosine kinase inhibitors

Ibrutinib is an irreversible inhibitor of Bruton tyrosine kinase (Btk) that is approved for the treatment of chronic lymphocytic leukemia and indolent non-Hodgkin lymphomas...

Read More